Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Y Han

Showing results (181-190 of 380) with videos related to

Pageof 38
Sort By:
Cancer Research|June 30, 2001
Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancersM S Shin, H S Kim, S H Lee, et al.
Nature Cell Biology|August 7, 2025
Evolutionarily conserved role of telomerase reverse transcriptase in programming the microenvironment via regulation of the cGAS-STING pathwaySemih Can Akincilar, Kerem Fidan, Naveen Kumar, et al.
Cancer Research|December 3, 1999
Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancersS H Lee, M S Shin, H S Kim, et al.
Cancer Research|December 3, 1999
Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomasS H Lee, M S Shin, H S Kim, et al.
Endocrinology|January 12, 2012
Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db miceD H Nam, M H Lee, J E Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2018
Long-term survival in patients with advanced non-small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK studyJ von Pawel, R Bordoni, M Satouchi, et al.
Clinical Pharmacology and Therapeutics|July 29, 2010
Pharmacokinetics of oltipraz and its major metabolite (RM) in patients with liver fibrosis or cirrhosis: relationship with suppression of circulating TGF-beta1S G Kim, Y M Kim, Y H Choi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2020
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trialM Schuler, R Berardi, W-T Lim, et al.
Gut|September 22, 2005
Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in miceK Tomita, G Tamiya, S Ando, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Cell fate specification during respiratory development requires ARID1A-containing canonical BAF complex activityHyunwook Lee, Abigail Jaquish, Sharlene Fernandes, et al.
Pageof 38

Showing results (181-190 of 380) with videos related to

Sort By:
Pageof 38
Cancer Research|June 30, 2001
Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancersM S Shin, H S Kim, S H Lee, et al.
Nature Cell Biology|August 7, 2025
Evolutionarily conserved role of telomerase reverse transcriptase in programming the microenvironment via regulation of the cGAS-STING pathwaySemih Can Akincilar, Kerem Fidan, Naveen Kumar, et al.
Cancer Research|December 3, 1999
Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancersS H Lee, M S Shin, H S Kim, et al.
Cancer Research|December 3, 1999
Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomasS H Lee, M S Shin, H S Kim, et al.
Endocrinology|January 12, 2012
Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db miceD H Nam, M H Lee, J E Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2018
Long-term survival in patients with advanced non-small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK studyJ von Pawel, R Bordoni, M Satouchi, et al.
Clinical Pharmacology and Therapeutics|July 29, 2010
Pharmacokinetics of oltipraz and its major metabolite (RM) in patients with liver fibrosis or cirrhosis: relationship with suppression of circulating TGF-beta1S G Kim, Y M Kim, Y H Choi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2020
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trialM Schuler, R Berardi, W-T Lim, et al.
Gut|September 22, 2005
Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in miceK Tomita, G Tamiya, S Ando, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Cell fate specification during respiratory development requires ARID1A-containing canonical BAF complex activityHyunwook Lee, Abigail Jaquish, Sharlene Fernandes, et al.
Pageof 38